STAT3 and small cell lung carcinoma: We found that in both SCLC cell lines, STAT3 levels decreased significantly, supporting the notion that CT20p could be inhibiting the protein-folding activity of CCT and causing loss of client proteins like STAT3 (Figure 4D).